vs
Side-by-side financial comparison of Allstate (ALL) and Astrana Health, Inc. (ASTH). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $922.0M, roughly 1.0× Allstate). Allstate runs the higher net margin — 266.6% vs 0.7%, a 265.9% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 7.2%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -75.8%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
ALL vs ASTH — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $922.0M | $950.5M |
| Net Profit | $2.5B | $6.6M |
| Gross Margin | — | — |
| Operating Margin | -1400.3% | 1.9% |
| Net Margin | 266.6% | 0.7% |
| Revenue YoY | 7.2% | 42.9% |
| Net Profit YoY | — | 184.4% |
| EPS (diluted) | $9.25 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $922.0M | — | ||
| Q4 25 | $17.3B | $950.5M | ||
| Q3 25 | $17.3B | $956.0M | ||
| Q2 25 | $16.6B | $654.8M | ||
| Q1 25 | $16.5B | $620.4M | ||
| Q4 24 | $16.5B | $665.2M | ||
| Q3 24 | $16.6B | $478.7M | ||
| Q2 24 | $15.7B | $486.3M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $3.8B | $6.6M | ||
| Q3 25 | $3.7B | $373.0K | ||
| Q2 25 | $2.1B | $9.4M | ||
| Q1 25 | $595.0M | $6.7M | ||
| Q4 24 | $1.9B | $-7.8M | ||
| Q3 24 | $1.2B | $16.1M | ||
| Q2 24 | $331.0M | $19.2M |
| Q1 26 | -1400.3% | — | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 3.1% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 6.2% |
| Q1 26 | 266.6% | — | ||
| Q4 25 | 22.1% | 0.7% | ||
| Q3 25 | 21.7% | 0.0% | ||
| Q2 25 | 12.7% | 1.4% | ||
| Q1 25 | 3.6% | 1.1% | ||
| Q4 24 | 11.7% | -1.2% | ||
| Q3 24 | 7.2% | 3.4% | ||
| Q2 24 | 2.1% | 3.9% |
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $0.12 | ||
| Q3 25 | $13.95 | $0.01 | ||
| Q2 25 | $7.76 | $0.19 | ||
| Q1 25 | $2.11 | $0.14 | ||
| Q4 24 | $7.07 | $-0.14 | ||
| Q3 24 | $4.33 | $0.33 | ||
| Q2 24 | $1.13 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $429.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $31.6B | $779.3M |
| Total Assets | $124.0B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $429.5M | ||
| Q3 25 | $8.7B | $463.4M | ||
| Q2 25 | $9.6B | $342.1M | ||
| Q1 25 | $6.5B | $260.9M | ||
| Q4 24 | $4.5B | $290.8M | ||
| Q3 24 | $7.0B | $350.3M | ||
| Q2 24 | $5.3B | $327.7M |
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | — | ||
| Q3 25 | $8.1B | — | ||
| Q2 25 | $8.1B | — | ||
| Q1 25 | $8.1B | — | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.1B | — |
| Q1 26 | $31.6B | — | ||
| Q4 25 | $30.6B | $779.3M | ||
| Q3 25 | $27.5B | $775.5M | ||
| Q2 25 | $24.0B | $765.5M | ||
| Q1 25 | $22.1B | $745.4M | ||
| Q4 24 | $21.4B | $712.7M | ||
| Q3 24 | $20.9B | $704.6M | ||
| Q2 24 | $18.6B | $678.9M |
| Q1 26 | $124.0B | — | ||
| Q4 25 | $119.8B | $2.2B | ||
| Q3 25 | $120.4B | $2.2B | ||
| Q2 25 | $115.9B | $1.4B | ||
| Q1 25 | $115.2B | $1.3B | ||
| Q4 24 | $111.6B | $1.4B | ||
| Q3 24 | $113.7B | $1.3B | ||
| Q2 24 | $108.4B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.37× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-2.9M |
| Free Cash FlowOCF − Capex | — | $-6.0M |
| FCF MarginFCF / Revenue | — | -0.6% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | -0.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | $104.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-2.9M | ||
| Q3 25 | $3.3B | $10.0M | ||
| Q2 25 | $1.9B | $90.9M | ||
| Q1 25 | $2.0B | $16.6M | ||
| Q4 24 | $1.7B | $-10.9M | ||
| Q3 24 | $3.2B | $34.0M | ||
| Q2 24 | $2.4B | $23.2M |
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $-6.0M | ||
| Q3 25 | $3.2B | $7.4M | ||
| Q2 25 | $1.9B | $89.5M | ||
| Q1 25 | $1.9B | $13.6M | ||
| Q4 24 | $1.7B | $-13.5M | ||
| Q3 24 | $3.1B | $31.7M | ||
| Q2 24 | $2.3B | $20.4M |
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | -0.6% | ||
| Q3 25 | 18.8% | 0.8% | ||
| Q2 25 | 11.3% | 13.7% | ||
| Q1 25 | 11.4% | 2.2% | ||
| Q4 24 | 10.0% | -2.0% | ||
| Q3 24 | 18.9% | 6.6% | ||
| Q2 24 | 14.7% | 4.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 0.3% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 0.3% | 0.4% | ||
| Q3 24 | 0.4% | 0.5% | ||
| Q2 24 | 0.4% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | -0.44× | ||
| Q3 25 | 0.88× | 26.69× | ||
| Q2 25 | 0.89× | 9.65× | ||
| Q1 25 | 3.30× | 2.48× | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 2.69× | 2.11× | ||
| Q2 24 | 7.13× | 1.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALL
Segment breakdown not available.
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
